Device Trial Radar · NCT03962517
Effect of GEMS-H on Locomotor Function in Adults
Last checked: Nov 20, 2026Latest source record: Apr 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
May 28, 2019
Primary completion
Feb 5, 2020
Study completion Feb 5, 2020
Sponsor
- Lead sponsor
- Samsung ElectronicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 24, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 19 years, up to 84 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the effect of training with the Gait Enhancing and Motivating System-Hip (GEMS-H) vs. training without the GEMS-H on locomotor function in adults. The investigator hypothesizes that long-term GEMS-H use would improve locomotor function. Specifically, individuals in the GEMS-H group will show faster gait speed compared to those in the control group.
Conditions
- Adults
- Middle Age
- Aged
- Aged, 80 and Over
Interventions
with Gait Enhancing and Motivating System-Hip (GEMS-H)Device
The intensity of training: between 12 and 16 in borg's rating of perceived exertion scale. Assessments consist of gait function, cardiopulmonary metabolic energy cost, physical performance, balance, physical level, pain, fall efficacy, depression, quality of life and activities of daily living.
without Gait Enhancing and Motivating System-Hip (GEMS-H)Other
The intensity of training: between 12 and 16 in borg's rating of perceived exertion scale.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in 10 Meter Walk Test-Self Selected Velocity (sec) from Baseline to Post-Training AssessmentTime frame: Baseline Assessment, Post Training Assessment (6 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Samsung Medical Center
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.